| Circulating miR-29a and miR-150 correlate with delivered dose during thoracic radiation therapy for non-small cell lung cancer TKT Dinh, W Fendler, J Chałubińska-Fendler, SS Acharya, C O’Leary, ... Radiation oncology 11, 1-11, 2016 | 133 | 2016 |
| ALC1 links chromatin accessibility to PARP inhibitor response in homologous recombination-deficient cells P Verma, Y Zhou, Z Cao, PV Deraska, M Deb, E Arai, W Li, Y Shao, ... Nature cell biology 23 (2), 160-171, 2021 | 101 | 2021 |
| CHK1 inhibitor blocks phosphorylation of FAM122A and promotes replication stress F Li, D Kozono, P Deraska, T Branigan, C Dunn, XF Zheng, K Parmar, ... Molecular cell 80 (3), 410-422. e6, 2020 | 47 | 2020 |
| USP9X inhibition promotes radiation-induced apoptosis in non-small cell lung cancer cells expressing mid-to-high MCL1 D Kushwaha, C O’Leary, KR Cron, P Deraska, K Zhu, AD D’Andrea, ... Cancer biology & therapy 16 (3), 392-401, 2015 | 47 | 2015 |
| Efficacy of analgesic treatments to manage children’s postoperative pain after laparoscopic appendectomy: retrospective medical record review RCB Manworren, CD McElligott, PV Deraska, J Santanelli, S Blair, ... AORN journal 103 (3), 317. e1-317. e11, 2016 | 32 | 2016 |
| MMB-FOXM1-driven premature mitosis is required for CHK1 inhibitor sensitivity TB Branigan, D Kozono, AE Schade, P Deraska, HG Rivas, L Sambel, ... Cell reports 34 (9), 2021 | 27 | 2021 |
| NF-κB inhibition by dimethylaminoparthenolide radiosensitizes non-small-cell lung carcinoma by blocking DNA double-strand break repair PV Deraska, C O’Leary, HD Reavis, S Labe, TK Dinh, JB Lazaro, ... Cell death discovery 4 (1), 10, 2018 | 17 | 2018 |
| Homologous recombination pathway-based biomarkers for treatment of non-small cell lung cancer with PARP inhibitors PV Deraska, HD Reavis, S Labe, AD D'Andrea, D Kozono Cancer Research 77 (13_Supplement), 4189-4189, 2017 | 2 | 2017 |
| Whole-genome CRISPR/Cas9 screen of the CHK1 inhibitor prexasertib implicates FAM122A loss as a potential resistance mechanism P Deraska, H Reavis, S Labe, A D'Andrea, D Kozono Cancer Research 78 (13_Supplement), 4287-4287, 2018 | 1 | 2018 |
| (476) Efficacy analysis of analgesic protocols to manage children’s post-operative pain after laparascopic appendectomy: retrospective analysis P Deraska, C McElligott, R Manworren, K Ruscher, R Weiss, C Rader, ... The Journal of Pain 15 (4), S95, 2014 | 1 | 2014 |
| Understanding the Role of ALC1-Dependent Chromatin Remodeling in Mediating PARP-Inhibitor Sensitivity P Deraska Boston University, 2020 | | 2020 |
| Exploiting Homologous Recombination Defects in N on-Small Cell Lung Cancer Through Combined PARP and Wee1 Inhibition D Yang, C O'Leary, PV Deraska, AD D'Andrea, DA Haas-Kogan, ... International Journal of Radiation Oncology, Biology, Physics 96 (2), E581-E582, 2016 | | 2016 |
| Whole-genome RNAi screen identified BCAS1 as a novel modifier of non-small cell lung carcinoma radioresistance C O’Leary, P Deraska, A D’Andrea, D Kozono Cancer Research 76 (14_Supplement), 1650-1650, 2016 | | 2016 |
| NF-κB inhibitor DMAPT blocks non-homologous end-joining repair of radiation-induced DSBs in NSCLC PV Deraska, C O’Leary, JB Lazaro, CJ Sweeney, AD D’Andrea, D Kozono Cancer Research 76 (14_Supplement), 1644-1644, 2016 | | 2016 |
